Hermann Haller

Hermann Haller

GERMANY

 

 

 

 

Date of birth 17 April 1953
Current position Full Professor and Chair, Division of Nephrology, Hannover Medical School Address Department of Nephrology and Hypertension, Hannover Medical School
EDUCATION AND TRAINING
University education
1976-1979 History of Arts, FU Berlin
1976-1982 Medical school, FU Berlin
1982 MD at the Free University Berlin, Department of Endocrinology
Postgraduate Training
1982-1992 Internal Medicine, University Hospital Benjamin Franklin, FU Berlin
1987-1989 Postdoctoral Research Fellow, Yale University, Medical School, Division of Endocrinology (Prof. H. Rasmussen)
1982 Approbation – Medical License
1991 Residency Internal Medicine (24.10.1991)
1998 Residency Nephrologist (18.03.1998)
Habilitation
1992 Internal Medicine (FU Berlin), “Molecular mechanisms of cardiovascular
hypertrophy“
APPOINTMENTS AND POSITIONS
1991-1993 Assistant Professor of Medicine, University Clinic Benjamin Franklin, Berlin (1991-1993),
1992-1999 Vice-Director, Division of Nephrology, Franz-Volhard-Clinic, Humboldt University Berlin
1993-1999 Associate Professor (C3), Humboldt-University Berlin and Coordinator:
Research Area Hypertension, Max-Delbrück-Centrum für Molekulare
Medizin (MDC), Berlin-Buch 2
1999 – Director, Department of Nephrology and Hypertension, Hannover
Medical School
2002 – 2011 Dean of Medical Education (Studiendekan), Hannover Medical School
2007- Coordinator: Integrated research and treatment centre for
transplantation (IFB), Hannover Medical School
2007- Faculty of the MDIBL – Mount Desert Island Biological Laboratory
2011- Honorary Professor of Huazhong University of Science and Technology
in Wuhan, China
2011- Director of Sino-German Clinical Trial Centre of Tongji Hospital
2014- Head of Management of International Affairs, Hannover Medical School
MAJOR SCIENTIFIC INTERESTS
 Pathogenesis and consequences of hypertension
 Kidney and vessel injury and regeneration
SELECTED HONORS AND AWARDS
1994 Franz Volhard Prize of the Society of Nephrology
1996 Walter Clawitter Prize of the Heinrich Heine University, Düsseldorf
1997 Pergamon-von-Galenus-Preis
2000 Franz Volhard Prize, German Hypertension Society
2005 Björn Folkow Award, European Society of Hypertension
2007 Jan Brod Prize, Czech Society of Hypertension
2010 Prize of the German Lodge of Druidism
2014 „Wennerström Lecture“ of Göteburg Sahlgrenska University Hospital
Scientific Board
– DFG (Deutsche Forschungsgemeinschaft) Fachgutachter für Nephrologie
SELECTED PUBLICATIONS
1. Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, Mimran A, Rabelink TJ,
Ritz E, Ruilope LM, Rump LC, Viberti G; ROADMAP Trial Investigators. Olmesartan for
the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med. 2011
Mar 10;364(10):907-17.
2. Ashworth S, Teng B, Kaufeld J, Miller E, Tossidou I, Englert C, Bollig F, Staggs L,
Roberts IS, Park JK, Haller H, Schiffer M. Cofilin-1 inactivation leads to proteinuria–
studies in zebrafish, mice and humans.PLoS One. 2010 Sep 8;5(9):e12626.
3. Gueler F, Park JK, Rong S, Kirsch T, Lindschau C, Zheng W, Elger M, Fiebeler A, Fliser D,
Luft FC, Haller H.Statins attenuate ischemia-reperfusion injury by inducing heme
oxygenase-1 in infiltrating macrophages. Am J Pathol.2007Apr;170(4):1192-9.
4. Meier M, Menne J, Park JK, Holtz M, Gueler F, Kirsch T, Schiffer M, Mengel M, Lindschau C, Leitges M, Haller H. Deletion of protein kinase C-epsilon
signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis
in vivo.J Am Soc Nephrol. 2007 Apr;18(4):1190-8.
5. Meier M, Park JK, Overheu D, Kirsch T, Lindschau C, Gueler F, Leitges M, Menne J,
Haller H. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozoticin-induced diabetic mouse model.Diabetes.
2007 Feb;56(2):346-54.
6. Schwarz A, Gwinner W, Hiss M, Radermacher J, Mengel M, Haller H. Safety and adequacy of renal transplant protocol biopsies
.Am J Transplant. 2005 Aug;5(8):1992-
7. Kiyan J, Kiyan R, Haller H, Dumler I. Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR -beta.EMBO J.
2005 May 18;24(10):1787- 97. Epub 2005 May 5.
8. Radermacher J, Mengel M, Ellis S, Stuht S, Hiss M, Schwarz A, Eisenberg U, Burg M, Luft FC, Gwinner W, Haller H. The renal arterial resistance index and renal allograft survival. N Engl J Med. 2003 Jul 10; 349(2):115-24.
9. Kielstein JT, Bode-Boger SM, Haller H, Fliser D. Functional changes in the ageing kidney: is there a role for asymmetric dimethylarginine?
Nephrol Dial Transplant. 2003 Jul:18(7):1245-8.
10. Elger M, Hentschel H, Litteral J, Wellner M, Kirsch T, Luft FC, Haller H. Nephrogenesis Is induced by Partial Nephrectomy in the Elasmobranch
Leucoraja erinacea. J Am Soc Nephrol. 2003 Jun; 14(6):1506-18.
11. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Koch KM, Haller H. Use of Doppler Ultrasonography to Predict
the Outcome of Therapy for Renal-Artery Stenosis. N Engl J Med. 2001; 344(6):410-417.